Uni-Bio Science Group Ltd. (HK:0690) has released an update.
Uni-Bio Science Group Ltd. has reported a robust interim financial performance for the first half of 2024, with a 9.5% year-on-year increase in revenue to HK$273.6 million and an impressive 71% jump in profits, reaching HK$67.4 million. The Group’s gross profit margin improved significantly to 84.3%, and the launch of new products such as Bogutai and the skincare line Skbrella™ FN is expected to contribute to future sales growth. Additionally, the company has demonstrated strong cost control with a decrease in general and administrative expenses as a percentage of revenue.
For further insights into HK:0690 stock, check out TipRanks’ Stock Analysis page.
